1. Home
  2. MD vs ABCL Comparison

MD vs ABCL Comparison

Compare MD & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MD
  • ABCL
  • Stock Information
  • Founded
  • MD 1979
  • ABCL 2012
  • Country
  • MD United States
  • ABCL Canada
  • Employees
  • MD N/A
  • ABCL N/A
  • Industry
  • MD Hospital/Nursing Management
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • MD Health Care
  • ABCL Health Care
  • Exchange
  • MD Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • MD 1.0B
  • ABCL 895.0M
  • IPO Year
  • MD 1995
  • ABCL 2020
  • Fundamental
  • Price
  • MD $14.01
  • ABCL $2.68
  • Analyst Decision
  • MD Buy
  • ABCL Buy
  • Analyst Count
  • MD 7
  • ABCL 3
  • Target Price
  • MD $15.36
  • ABCL $8.50
  • AVG Volume (30 Days)
  • MD 644.8K
  • ABCL 2.4M
  • Earning Date
  • MD 11-01-2024
  • ABCL 11-04-2024
  • Dividend Yield
  • MD N/A
  • ABCL N/A
  • EPS Growth
  • MD N/A
  • ABCL N/A
  • EPS
  • MD N/A
  • ABCL N/A
  • Revenue
  • MD $2,006,998,000.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • MD $3.13
  • ABCL N/A
  • Revenue Next Year
  • MD N/A
  • ABCL $36.56
  • P/E Ratio
  • MD N/A
  • ABCL N/A
  • Revenue Growth
  • MD N/A
  • ABCL N/A
  • 52 Week Low
  • MD $6.62
  • ABCL $2.34
  • 52 Week High
  • MD $16.41
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • MD 46.08
  • ABCL 44.26
  • Support Level
  • MD $13.90
  • ABCL $2.76
  • Resistance Level
  • MD $14.70
  • ABCL $3.05
  • Average True Range (ATR)
  • MD 0.44
  • ABCL 0.16
  • MACD
  • MD -0.12
  • ABCL -0.03
  • Stochastic Oscillator
  • MD 21.67
  • ABCL 0.00

About MD Pediatrix Medical Group Inc.

Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment and generates majority of the revenue through neonatology and other pediatric subspecialties.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: